Structural and Clinical Predictors of Cognitive Impairment After Surgical Treatment for Ruptured Cerebral Aneurysms
SCOPE-aSAH
1 other identifier
observational
150
1 country
1
Brief Summary
This study investigates the clinical and structural predictors of long-term cognitive impairment in patients who underwent microsurgical clipping for aneurysmal subarachnoid hemorrhage. Using a retrospective cohort with prospective neuropsychological and MRI assessments, it aims to identify factors associated with late cognitive deficits and improve prognostic stratification, rehabilitation planning, and long-term patient care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2026
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 16, 2026
CompletedFirst Posted
Study publicly available on registry
July 23, 2026
CompletedStudy Start
First participant enrolled
August 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2029
July 23, 2026
July 1, 2026
2.9 years
July 16, 2026
July 20, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Montreal Cognitive Assessment (MoCA) score
The MoCA is a global cognitive screening test with scores ranging from 0 to 30, where higher scores indicate better cognitive function. Cognitive impairment is defined as a MoCA score \<25, adjusted for educational level. A secondary analysis will also classify participants with MoCA \<23, adjusted for educational level, representing unfavorable functional outcome.
Through study completion, an average of 3 years
Secondary Outcomes (5)
EuroQol 5-Dimension 5-Level (EQ-5D-5L)
Through study completion, an average of 3 years
Hospital Anxiety and Depression Scale (HADS)
Through study completion, an average of 3 years
Modified Rankin Scale (mRS)
Through study completion, an average of 3 years
Return to work
Through study completion, an average of 3 years
In-hospital complications
Through study completion, an average of 3 years
Study Arms (3)
Operated <24h
Patients submited to microsurgical clipping \<24h after aneurysmal subarachnoid hemorrhage
Operated 24-72h
Patients submited to microsurgical clipping between 24h and 72h after aneurysmal subarachnoid hemorrhage
Operated >72h
Patients submited to microsurgical clipping \>72h after aneurysmal subarachnoid hemorrhage
Eligibility Criteria
Adult patients who underwent microsurgical clipping of ruptured cerebral aneurysms following aneurysmal subarachnoid hemorrhage (aSAH), with symptom onset occurring in or after 2020, and who are currently under outpatient follow-up at HC-UNICAMP, will be eligible for inclusion.
You may qualify if:
- Age ≥18 years at the time of aSAH.
- Treatment by microsurgical clipping of a ruptured cerebral aneurysm.
- Survival until study recruitment.
- Ability to understand and sign informed consent.
You may not qualify if:
- Non-aneurysmal subarachnoid hemorrhage.
- Exclusively endovascular treatment.
- Previous diagnosis of dementia.
- Severe neurological or psychiatric disorders unrelated to aSAH with significant cognitive impact.
- Absolute contraindication to MRI.
- Severe aphasia preventing adequate neuropsychological evaluation.
- Incomplete clinical data.
- Inability to attend in-person assessment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Clinics Hospital - UNICAMP
Campinas, São Paulo, 13083888, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 16, 2026
First Posted
July 23, 2026
Study Start
August 1, 2026
Primary Completion (Estimated)
July 1, 2029
Study Completion (Estimated)
December 1, 2029
Last Updated
July 23, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
Yes. De-identified individual participant data will be made available upon reasonable request to the corresponding author, following publication of the primary results, subject to approval of a data access agreement and institutional/ethical requirements.